186 related articles for article (PubMed ID: 2922756)
1. In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models.
Reitz RH; Mendrala AL; Guengerich FP
Toxicol Appl Pharmacol; 1989 Feb; 97(2):230-46. PubMed ID: 2922756
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessment.
Reitz RH; Mendrala AL; Park CN; Andersen ME; Guengerich FP
Toxicol Lett; 1988 Oct; 43(1-3):97-116. PubMed ID: 3176073
[TBL] [Abstract][Full Text] [Related]
3. DNA-protein cross-links (DPX) and cell proliferation in B6C3F1 mice but not Syrian golden hamsters exposed to dichloromethane: pharmacokinetics and risk assessment with DPX as dosimeter.
Casanova M; Conolly RB; Heck H d'A
Fundam Appl Toxicol; 1996 May; 31(1):103-16. PubMed ID: 8998946
[TBL] [Abstract][Full Text] [Related]
4. Estimating the risk of human cancer associated with exposure to methylene chloride.
Reitz RH
Ann Ist Super Sanita; 1991; 27(4):609-14. PubMed ID: 1820733
[TBL] [Abstract][Full Text] [Related]
5. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.
Andersen ME; Clewell HJ; Gargas ML; Smith FA; Reitz RH
Toxicol Appl Pharmacol; 1987 Feb; 87(2):185-205. PubMed ID: 3824380
[TBL] [Abstract][Full Text] [Related]
6. The impact of exercise and intersubject variability on dose estimates for dichloromethane derived from a physiologically based pharmacokinetic model.
Dankovic DA; Bailer AJ
Fundam Appl Toxicol; 1994 Jan; 22(1):20-5. PubMed ID: 8125209
[TBL] [Abstract][Full Text] [Related]
7. Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans.
Andersen ME; Clewell HJ; Gargas ML; MacNaughton MG; Reitz RH; Nolan RJ; McKenna MJ
Toxicol Appl Pharmacol; 1991 Mar; 108(1):14-27. PubMed ID: 1900959
[TBL] [Abstract][Full Text] [Related]
8. Physiologically based pharmacokinetic modeling of inhalation exposure of humans to dichloromethane during moderate to heavy exercise.
Jonsson F; Bois F; Johanson G
Toxicol Sci; 2001 Feb; 59(2):209-18. PubMed ID: 11158713
[TBL] [Abstract][Full Text] [Related]
9. Application of PBPK modeling in support of the derivation of toxicity reference values for 1,1,1-trichloroethane.
Lu Y; Rieth S; Lohitnavy M; Dennison J; El-Masri H; Barton HA; Bruckner J; Yang RS
Regul Toxicol Pharmacol; 2008 Mar; 50(2):249-60. PubMed ID: 18226845
[TBL] [Abstract][Full Text] [Related]
10. Limited reactivity of formyl chloride with glutathione and relevance to metabolism and toxicity of dichloromethane.
Watanabe K; Guengerich FP
Chem Res Toxicol; 2006 Aug; 19(8):1091-6. PubMed ID: 16918250
[TBL] [Abstract][Full Text] [Related]
11. Methylene chloride induced mouse liver and lung tumours: an overview of the role of mechanistic studies in human safety assessment.
Green T
Hum Exp Toxicol; 1997 Jan; 16(1):3-13. PubMed ID: 9023569
[TBL] [Abstract][Full Text] [Related]
12. Comment on M.V. Evans and J.C. Caldwell: evaluation of two different metabolic hypotheses for dichloromethane toxicity using physiologically based pharmacokinetic modeling of in vivo gas uptake data exposure in female B6C3F1 mice, Toxicol. Appl. Pharmacol., 244, 280-290, 2010.
Anders MW; Andersen ME; Clewell HJ; Gargas ML; Guengerich FP; Reitz RH
Toxicol Appl Pharmacol; 2010 Oct; 248(1):63-4; author reply 65-7. PubMed ID: 20655322
[No Abstract] [Full Text] [Related]
13. Evaluation of two different metabolic hypotheses for dichloromethane toxicity using physiologically based pharmacokinetic modeling for in vivo inhalation gas uptake data exposure in female B6C3F1 mice.
Evans MV; Caldwell JC
Toxicol Appl Pharmacol; 2010 May; 244(3):280-90. PubMed ID: 20153349
[TBL] [Abstract][Full Text] [Related]
14. Physiologically based pharmacokinetic modeling with methylchloroform: implications for interspecies, high dose/low dose, and dose route extrapolations.
Reitz RH; McDougal JN; Himmelstein MW; Nolan RJ; Schumann AM
Toxicol Appl Pharmacol; 1988 Sep; 95(2):185-99. PubMed ID: 3420611
[TBL] [Abstract][Full Text] [Related]
15. Use of the vial equilibration technique for determination of metabolic rate constants for dichloromethane.
Kim C; Manning RO; Brown RP; Bruckner JV
Toxicol Appl Pharmacol; 1996 Aug; 139(2):243-51. PubMed ID: 8806840
[TBL] [Abstract][Full Text] [Related]
16. Dichloromethane metabolism to formaldehyde and reaction of formaldehyde with nucleic acids in hepatocytes of rodents and humans with and without glutathione S-transferase T1 and M1 genes.
Casanova M; Bell DA; Heck HD
Fundam Appl Toxicol; 1997 Jun; 37(2):168-80. PubMed ID: 9242590
[TBL] [Abstract][Full Text] [Related]
17. Dichloromethane (methylene chloride): metabolism to formaldehyde and formation of DNA-protein cross-links in B6C3F1 mice and Syrian golden hamsters.
Casanova M; Deyo DF; Heck H
Toxicol Appl Pharmacol; 1992 May; 114(1):162-5. PubMed ID: 1585369
[TBL] [Abstract][Full Text] [Related]
18. Determining kinetic constants of chlorinated ethane metabolism in the rat from rates of exhalation.
Gargas ML; Andersen ME
Toxicol Appl Pharmacol; 1989 Jun; 99(2):344-53. PubMed ID: 2734795
[TBL] [Abstract][Full Text] [Related]
19. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
20. Physiologically based pharmacokinetic model for vinylidene chloride.
D'Souza RW; Andersen ME
Toxicol Appl Pharmacol; 1988 Sep; 95(2):230-40. PubMed ID: 3420614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
